Enhancement of androgen receptor expression induced by (R)-methanandamide in prostate LNCaP cells.
about
Cannabinoids as therapeutic agents in cancer: current status and future implicationsPreclinical and Clinical Assessment of Cannabinoids as Anti-Cancer AgentsTumour Cannabinoid CB(1) receptor and phosphorylated epidermal growth factor receptor expression are additive prognostic markers for prostate cancer.Association between cannabinoid CB₁ receptor expression and Akt signalling in prostate cancer.Inhibition of human tumour prostate PC-3 cell growth by cannabinoids R(+)-Methanandamide and JWH-015: involvement of CB2Cannabinoids and cancer: pros and cons of an antitumour strategy.The endocannabinoid system and cancer: therapeutic implication.Pharmacogenetics of human androgens and prostate cancer--an update.Modulation of breast cancer cell viability by a cannabinoid receptor 2 agonist, JWH-015, is calcium dependent.Critical appraisal of the potential use of cannabinoids in cancer management.Changes in the endocannabinoid system may give insight into new and effective treatments for cancer.Roles of Eicosanoids in Prostate Cancer.The endocannabinoid system in prostate cancer.Delta(9) -tetrahydrocannabinol and cannabidiol as potential curative agents for cancer: A critical examination of the preclinical literature.Phyto-, endo- and synthetic cannabinoids: promising chemotherapeutic agents in the treatment of breast and prostate carcinomas.Effects of cannabinoids and related fatty acids upon the viability of P19 embryonal carcinoma cells.Expression and secretion of N-acylethanolamine-hydrolysing acid amidase in human prostate cancer cells.Bladder cancer cell growth and motility implicate cannabinoid 2 receptor-mediated modifications of sphingolipids metabolismINSIGHT ON THE IMPACT OF ENDOCANNABINOID SYSTEM IN CANCER: A REVIEW.
P2860
Q26866298-C5512FDB-1ECD-45DB-A95B-A780A01EB921Q28075903-ADBC9736-3B33-4F1C-9638-170D5DC90FDBQ33784488-0BFCE517-E2D8-4718-B8E1-1712227AF972Q34766747-5923D442-B592-41FF-B819-A0980DE33F1AQ34998169-E6FE2BCA-8841-45AF-BBF4-F74B458C70CDQ35100892-47BE7BBF-453D-4DE0-AEEC-86C64E6332C2Q35193299-41CEDBA2-FC69-4179-8975-DE0B300D92F9Q35753329-0F0DAB42-C2AE-40AC-B077-563AC3D5111AQ36843205-D8CA988C-9D60-40BE-B23F-AB06A1B61F90Q37164208-FA22841B-AE7E-457D-B9E2-59C81B090BAFQ37568679-AD1418FE-80DC-411B-ADED-796E5BA2E6DAQ37592857-14A2BC07-BBDC-4042-927C-EE320244FDA3Q37930973-F3F629C1-BB32-4A91-BE3E-E47E0EC02051Q38351132-39F8AE60-909B-4C75-BB7D-B16FF2F9C855Q38955546-4ECE4FE6-490F-4913-B8C3-077FF4C3B0B3Q39172074-B4956864-B743-437E-9FF2-B70680A1EE7EQ39937512-01634C0F-EE48-405E-AC01-41D88C920997Q42052824-638AB58A-A958-476C-A6B0-9A926ABFF160Q52583978-F320B64C-7C1A-4151-A808-BC625A86055E
P2860
Enhancement of androgen receptor expression induced by (R)-methanandamide in prostate LNCaP cells.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Enhancement of androgen recept ...... amide in prostate LNCaP cells.
@en
type
label
Enhancement of androgen recept ...... amide in prostate LNCaP cells.
@en
prefLabel
Enhancement of androgen recept ...... amide in prostate LNCaP cells.
@en
P2093
P2860
P1433
P1476
Enhancement of androgen recept ...... amide in prostate LNCaP cells.
@en
P2093
Ana M Sánchez
Inés Díaz-Laviada
Lidia Ruiz-Llorente
María G Sánchez
P2860
P304
P356
10.1016/S0014-5793(03)01349-8
P407
P577
2003-12-01T00:00:00Z